Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

RENEE M MARCHIONI BEERY

Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology

NPI
1750618955
CMS profile
79380
Location
TAMPA, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2023 · Entire year

$31,854.33

102 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2023 · entire year · sorted by reported total

By paying entity

PY2023 · entire year · sorted by reported total

Page 1 of 3; records 1–50 of 102 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

RENEE M MARCHIONI BEERY

NPI 1750618955 · CMS profile ID 79380

Allopathic & Osteopathic Physicians / Internal Medicine / Gastroenterology

TAMPA, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 3; records 1–50 of 102 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1750618955?year=2023&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
RENEE M MARCHIONI BEERY, NPI 1750618955, CMS profile ID 79380. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 3; records 1–50 of 102 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1750618955?year=2023&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
APA 7
IndustryPayments. (2026). RENEE M MARCHIONI BEERY, NPI 1750618955, CMS profile ID 79380. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 3; records 1–50 of 102 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1750618955?year=2023&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
Bluebook
RENEE M MARCHIONI BEERY, NPI 1750618955, CMS profile ID 79380, IndustryPayments, General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 3; records 1–50 of 102 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9. https://industrypayments.org/provider/npi-1750618955?year=2023&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30

102 matching records · $31,854.33 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 102 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–50 of 102.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
ABBVIE INC. $3,375.0012/26/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997838937 CMS
ABBVIE INC. $3,375.0012/20/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997838933 CMS
ABBVIE INC. $3,375.0012/20/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997838935 CMS
ABBVIE INC. $449.2012/19/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997838929 CMS
ABBVIE INC. $14.9912/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997838931 CMS
Celgene Corporation $20.7912/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015516095 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $8.0312/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1057137381 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $6.4312/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1057338169 CMS
ABBVIE INC. $29.0512/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997838925 CMS
ABBVIE INC. $15.9712/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997838927 CMS
ABBVIE INC. $3,375.0012/12/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997838923 CMS
ABBVIE INC. $30.1312/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997838921 CMS
Celgene Corporation $0.5712/05/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015516067 CMS
Celgene Corporation $20.3212/05/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015516071 CMS
PFIZER INC. $19.4112/01/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050593885 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $6.9611/29/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1057327191 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $0.7611/29/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1057494719 CMS
ABBVIE INC. $9.2911/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997838919 CMS
ABBVIE INC. $22.4411/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997838917 CMS
ABBVIE INC. $3,375.0011/06/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997838915 CMS
PFIZER INC. $15.2511/02/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050583215 CMS
ABBVIE INC. $4.1610/26/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997838911 CMS
ABBVIE INC. $125.0010/26/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997838913 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $21.8710/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1057296449 CMS
ABBVIE INC. $6.0910/24/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997838909 CMS
QOL Medical, LLC $15.2110/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1059301293 CMS
ABBVIE INC. $5.0610/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997838907 CMS
Celgene Corporation $5.2810/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015516011 CMS
ABBVIE INC. $19.8310/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997838905 CMS
Janssen Scientific Affairs, LLC $15.5210/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988759667 CMS
Celgene Corporation $0.4410/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015516003 CMS
Celgene Corporation $21.4010/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015516007 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $10.5210/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1057268023 CMS
Celgene Corporation $1.4610/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015515999 CMS
Lucid Diagnostics Inc. $15.4810/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1057655957 CMS
ABBVIE INC. $5.9309/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997838903 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $4.2609/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1057182049 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $0.2509/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1057292323 CMS
ABBVIE INC. $20.2309/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997838901 CMS
ABBVIE INC. $6.8609/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997838899 CMS
ABBVIE INC. $10.4209/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997838897 CMS
ABBVIE INC. $3,375.0008/29/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997838895 CMS
Celgene Corporation $24.1208/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015515959 CMS
ABBVIE INC. $103.3408/24/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997838893 CMS
ABBVIE INC. $7.6308/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997838891 CMS
ABBVIE INC. $24.5608/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997838889 CMS
Sandoz Inc. $13.9808/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1028948929 CMS
ABBVIE INC. $5.3208/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997838887 CMS
Axonics, Inc. $15.8708/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051815283 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $22.5408/02/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1057173471 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $99.06 1
PY2020 $99.00 1
PY2021 $297.80 9
PY2022 $8,672.41 40
PY2023 $31,854.33 102
PY2024 $25,304.81 82
PY2025 $59,790.00 88

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $1,000.00 1
PY2024 Principal investigator $86.00 3
PY2023 Principal investigator $1,739.00 25
PY2022 Principal investigator $50,249.30 34
PY2021 Principal investigator $69,719.70 7
PY2020 Principal investigator $14,395.08 5

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2022

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

34 records in PY2022

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 ARENA PHARMACEUTICALS, INC. $28.00 12/30/2022 Non-covered Recipient Entity
USF Deparment of Surgery
AN OPENLABEL EXTENSION STUDY OF ETRASIMOD IN SUBJECTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS No dispute reported 06/30/2026 949769659
Principal investigator 1 ARENA PHARMACEUTICALS, INC. $28.00 12/30/2022 Non-covered Recipient Entity
USF Deparment of Surgery
AN OPENLABEL EXTENSION STUDY OF ETRASIMOD IN SUBJECTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS No dispute reported 06/30/2026 949771187
Principal investigator 1 ARENA PHARMACEUTICALS, INC. $28.00 11/30/2022 Non-covered Recipient Entity
USF Deparment of Surgery
AN OPENLABEL EXTENSION STUDY OF ETRASIMOD IN SUBJECTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS No dispute reported 06/30/2026 949770215
Principal investigator 1 ARENA PHARMACEUTICALS, INC. $28.00 11/30/2022 Non-covered Recipient Entity
USF Deparment of Surgery
AN OPENLABEL EXTENSION STUDY OF ETRASIMOD IN SUBJECTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS No dispute reported 06/30/2026 949771121
Principal investigator 1 ARENA PHARMACEUTICALS, INC. $28.00 10/31/2022 Non-covered Recipient Entity
USF Deparment of Surgery
AN OPENLABEL EXTENSION STUDY OF ETRASIMOD IN SUBJECTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS No dispute reported 06/30/2026 949770403
Principal investigator 1 ARENA PHARMACEUTICALS, INC. $28.00 10/31/2022 Non-covered Recipient Entity
USF Deparment of Surgery
AN OPENLABEL EXTENSION STUDY OF ETRASIMOD IN SUBJECTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS No dispute reported 06/30/2026 949771119
Principal investigator 1 ARENA PHARMACEUTICALS, INC. $60.00 10/12/2022 Non-covered Recipient Entity
USF Deparment of Surgery
AN OPENLABEL EXTENSION STUDY OF ETRASIMOD IN SUBJECTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS No dispute reported 06/30/2026 949770217
Principal investigator 1 ARENA PHARMACEUTICALS, INC. $28.00 09/30/2022 Non-covered Recipient Entity
USF Deparment of Surgery
AN OPENLABEL EXTENSION STUDY OF ETRASIMOD IN SUBJECTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS No dispute reported 06/30/2026 949767121
Principal investigator 1 ARENA PHARMACEUTICALS, INC. $28.00 09/30/2022 Non-covered Recipient Entity
USF Deparment of Surgery
AN OPENLABEL EXTENSION STUDY OF ETRASIMOD IN SUBJECTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS No dispute reported 06/30/2026 949768521
Principal investigator 1 ARENA PHARMACEUTICALS, INC. $28.00 08/31/2022 Non-covered Recipient Entity
USF Deparment of Surgery
AN OPENLABEL EXTENSION STUDY OF ETRASIMOD IN SUBJECTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS No dispute reported 06/30/2026 949768429
Principal investigator 1 ARENA PHARMACEUTICALS, INC. $28.00 08/31/2022 Non-covered Recipient Entity
USF Deparment of Surgery
AN OPENLABEL EXTENSION STUDY OF ETRASIMOD IN SUBJECTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS No dispute reported 06/30/2026 949768431
Principal investigator 1 ARENA PHARMACEUTICALS, INC. $28.00 07/30/2022 Non-covered Recipient Entity
USF Deparment of Surgery
AN OPENLABEL EXTENSION STUDY OF ETRASIMOD IN SUBJECTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS No dispute reported 06/30/2026 949768269
Principal investigator 1 ARENA PHARMACEUTICALS, INC. $28.00 07/30/2022 Non-covered Recipient Entity
USF Deparment of Surgery
AN OPENLABEL EXTENSION STUDY OF ETRASIMOD IN SUBJECTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS No dispute reported 06/30/2026 949768519
Principal investigator 1 ARENA PHARMACEUTICALS, INC. $400.00 07/13/2022 Non-covered Recipient Entity
University of South Florida
AN OPENLABEL EXTENSION STUDY OF ETRASIMOD IN SUBJECTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS No dispute reported 06/30/2026 949768523
Principal investigator 1 ARENA PHARMACEUTICALS, INC. $5,231.70 07/08/2022 Non-covered Recipient Entity
University of South Florida
AN OPENLABEL EXTENSION STUDY OF ETRASIMOD IN SUBJECTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS No dispute reported 06/30/2026 949767119
Principal investigator 1 ARENA PHARMACEUTICALS, INC. $28.00 06/30/2022 Non-covered Recipient Entity
USF Deparment of Surgery
AN OPENLABEL EXTENSION STUDY OF ETRASIMOD IN SUBJECTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS No dispute reported 06/30/2026 949767449
Principal investigator 1 ARENA PHARMACEUTICALS, INC. $28.00 06/30/2022 Non-covered Recipient Entity
USF Deparment of Surgery
AN OPENLABEL EXTENSION STUDY OF ETRASIMOD IN SUBJECTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS No dispute reported 06/30/2026 949768593
Principal investigator 1 ARENA PHARMACEUTICALS, INC. $300.00 06/08/2022 Non-covered Recipient Entity
University of South Florida
AN OPENLABEL EXTENSION STUDY OF ETRASIMOD IN SUBJECTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS No dispute reported 06/30/2026 949767123
Principal investigator 1 ARENA PHARMACEUTICALS, INC. $60.00 06/08/2022 Non-covered Recipient Entity
University of South Florida
AN OPENLABEL EXTENSION STUDY OF ETRASIMOD IN SUBJECTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS No dispute reported 06/30/2026 949768587
Principal investigator 1 ARENA PHARMACEUTICALS, INC. $28.00 05/31/2022 Non-covered Recipient Entity
USF Deparment of Surgery
AN OPENLABEL EXTENSION STUDY OF ETRASIMOD IN SUBJECTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS No dispute reported 06/30/2026 949767125
Principal investigator 1 ARENA PHARMACEUTICALS, INC. $28.00 05/31/2022 Non-covered Recipient Entity
USF Deparment of Surgery
AN OPENLABEL EXTENSION STUDY OF ETRASIMOD IN SUBJECTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS No dispute reported 06/30/2026 949767291
Principal investigator 1 ARENA PHARMACEUTICALS, INC. $360.00 05/20/2022 Non-covered Recipient Entity
University of South Florida
AN OPENLABEL EXTENSION STUDY OF ETRASIMOD IN SUBJECTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS No dispute reported 06/30/2026 949768589
Principal investigator 1 Eli Lilly and Company $595.00 05/09/2022 Non-covered Recipient Entity
UNIV OF SOUTH FLORIDA RSRCH FOUNDATION
A PHASE 3, MULTICENTER, OPEN LABEL, LONG TERM EXTENSION STUDY TO EVALUATE THE LONG TERM EFFICACY AND SAFETY OF MIRIKIZUMAB IN PATIENTS WITH CROHNS DISEASE No dispute reported 06/30/2026 917839555
Principal investigator 1 ARENA PHARMACEUTICALS, INC. $375.00 05/04/2022 Non-covered Recipient Entity
University of South Florida
AN OPENLABEL EXTENSION STUDY OF ETRASIMOD IN SUBJECTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS No dispute reported 06/30/2026 949768425
Principal investigator 1 ARENA PHARMACEUTICALS, INC. $28.00 04/29/2022 Non-covered Recipient Entity
USF Deparment of Surgery
AN OPENLABEL EXTENSION STUDY OF ETRASIMOD IN SUBJECTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS No dispute reported 06/30/2026 949767293
Principal investigator 1 ARENA PHARMACEUTICALS, INC. $28.00 04/29/2022 Non-covered Recipient Entity
USF Deparment of Surgery
AN OPENLABEL EXTENSION STUDY OF ETRASIMOD IN SUBJECTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS No dispute reported 06/30/2026 949768427
Principal investigator 1 ARENA PHARMACEUTICALS, INC. $1,656.90 04/11/2022 Non-covered Recipient Entity
University of South Florida
AN OPENLABEL EXTENSION STUDY OF ETRASIMOD IN SUBJECTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS No dispute reported 06/30/2026 949767451
Principal investigator 1 ABBVIE INC. $500.00 03/31/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA
A Long-Term Registry of Humira?? (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC) No dispute reported 06/30/2026 889782893
Principal investigator 1 ARENA PHARMACEUTICALS, INC. $28.00 03/31/2022 Non-covered Recipient Entity
USF Deparment of Surgery
AN OPENLABEL EXTENSION STUDY OF ETRASIMOD IN SUBJECTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS No dispute reported 06/30/2026 949767295
Principal investigator 1 ARENA PHARMACEUTICALS, INC. $28.00 03/31/2022 Non-covered Recipient Entity
USF Deparment of Surgery
AN OPENLABEL EXTENSION STUDY OF ETRASIMOD IN SUBJECTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS No dispute reported 06/30/2026 949768591
Principal investigator 1 ARENA PHARMACEUTICALS, INC. $1,525.50 03/14/2022 Non-covered Recipient Entity
University of South Florida
AN OPENLABEL EXTENSION STUDY OF ETRASIMOD IN SUBJECTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS No dispute reported 06/30/2026 949767289
Principal investigator 1 Eli Lilly and Company $658.00 01/26/2022 Non-covered Recipient Entity
UNIV OF SOUTH FLORIDA RSRCH FOUNDATION
A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO- AND ACTIVE- CONTROLLED, TREAT-THROUGH STUDY TO EVALUATE THE EFFICACY AND SAFETY OF MIRIKIZUMAB IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE No dispute reported 06/30/2026 917839551
Principal investigator 1 Eli Lilly and Company $37,104.00 01/10/2022 Non-covered Recipient Entity
UNIV OF SOUTH FLORIDA RSRCH FOUNDATION
A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO- AND ACTIVE- CONTROLLED, TREAT-THROUGH STUDY TO EVALUATE THE EFFICACY AND SAFETY OF MIRIKIZUMAB IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE No dispute reported 06/30/2026 917846697
Principal investigator 1 ABBVIE INC. $863.20 01/07/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA
A Long-Term Registry of Humira?? (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC) No dispute reported 06/30/2026 889773009